Deborah Dunsire
CIK: 0001332764
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 22, 2026MCK
MCKESSON CORP
Award(A)DirectRestricted Stock Units (RSUs)
277 shares- - May 14, 2026RARE
Ultragenyx Pharmaceutical Inc.
Award(A)Direct7.8K shares- - Jul 30, 2025MCK
MCKESSON CORP
Award(A)DirectRestricted Stock Units (RSUs)
301 shares- - May 15, 2025RARE
Ultragenyx Pharmaceutical Inc.
Award(A)Direct5.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 22, 2026 |  MCK MCKESSON CORP | Award(A) Restricted Stock Units (RSUs) | 277 | - | - | Direct |
| May 14, 2026 |  RARE Ultragenyx Pharmaceutical Inc. | Award(A) | 7,751 | - | $0 | Direct |
| Jul 30, 2025 | MCK MCKESSON CORP | Award(A) Restricted Stock Units (RSUs) | 301 | - | - | Direct |
| May 15, 2025 | RARE Ultragenyx Pharmaceutical Inc. | Award(A) | 5,740 | - | - | Direct |
1-4 of 4 transactions
About Dunsire Deborah
Dunsire Deborah (SEC CIK 0001332764) files insider reports with the SEC as Director of MCKESSON CORP (MCK) and Director of Ultragenyx Pharmaceutical Inc. (RARE).
Signal8 holds 4 ownership filings by Dunsire Deborah, all Form 4s, filed between May 19, 2025 and Jul 23, 2026. Those filings report 4 transactions, from May 15, 2025 to Jul 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Dunsire Deborah's filings is in IRVING, TX.
Recent filings by Dunsire Deborah
Other insiders filing for MCKESSON CORP (MCK)
- Fraga Francisco, EVP, CIO and CTO
- Rutledge Napoleon B JR, SVP, Controller & CAO
- Srinivasan Ramesh (NMN), EVP and Chief Strategy Officer
- Lerman Bradley E, Director
- Hinton James H., Director
- Doughtie Lynne M, Director